A new chapter in the story of weight and medicine is being written not in clinics, but in the quiet suffering of patients who discover that stopping a drug can be harder than starting it. GLP-1 medications, celebrated for their appetite-suppressing power, are now drawing scrutiny for what happens when that power fades — intense, destabilizing cravings that some compare to opioid withdrawal. The medical community is being asked an old and difficult question in a new form: when a treatment changes the body profoundly, is it healing, or is it simply relocating the problem?
When Weight-Loss Drugs Fail: Managing Intense Cravings and Rebound Effects
Patients experience severe psychological distress including withdrawal-like symptoms and intense cravings when weight-loss medications cease effectiveness.